{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:40:45Z","timestamp":1761561645889},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T00:00:00Z","timestamp":1359072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Colorectal Disease"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim\u2002<\/jats:bold> Perianal disease affects 33% (range 8\u201390%) of patients with Crohn\u2019s disease. Fistulae are often complex and their management is often difficult and unsatisfactory. This study was a retrospective assessment of a combination of surgical treatment with a standardized protocol of infliximab (IFX) therapy.<\/jats:p><jats:p><jats:bold>Method\u2002<\/jats:bold> A consecutive series of patients with complex perianal Crohn\u2019s disease, presenting between January 2003 and June 2008, were included. Acute sepsis was initially treated with antibiotics and\/or surgical drainage (MRI guided when appropriate) and loose seton insertion. IFX was given at 5\u2003mg\/kg, at 0, 2 and 6\u2003weeks. End\u2010points were complete, partial or no response. Setons were empirically removed after the second cycle of IFX.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Forty\u2010eight patients, average age 46 (range 24\u201382)\u2003years, with perianal Crohn\u2019s disease were identified. Three patients stopped IFX after the second infusion, either because of allergy (two patients) or for failure to respond (one patient). Fourteen patients were given maintenance IFX at 8\u2010weekly intervals. Results were recorded for 48 patients, of whom 14 (29%) had a complete response, 20 (42%) had a partial response and 14 (29%) had no response to treatment. Outpatient follow\u2010up was for a median of 20\u2003months.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Combining surgical procedures with IFX resulted in complete and partial remission in 29% and 42% of patients, respectively. No serious side effects occurred. Using a combined, intensive medico\u2010surgical approach, good initial control of perianal disease was achieved safely.<\/jats:p>","DOI":"10.1111\/j.1463-1318.2012.03124.x","type":"journal-article","created":{"date-parts":[[2012,6,3]],"date-time":"2012-06-03T12:23:40Z","timestamp":1338726220000},"page":"210-216","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Combined modality treatment for complex fistulating perianal Crohn\u2019s disease"],"prefix":"10.1111","volume":"15","author":[{"given":"R.","family":"Antakia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Shorthouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,1,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.1996.tb00690.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003840050051"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02054227"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.6.525"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3182099d9e"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32362"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4263"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905063401804"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-6611-4"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2004.00749.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800630102"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200303000-00003"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-005-0288-1"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-006-0695-y"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.043372"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00759-7"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(80)90155-9"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","article-title":"Metronidazole therapy for perianal Crohn\u2019s disease: a follow\u2010up study","volume":"83","author":"Brandt LJ","year":"1982","journal-title":"Gastroenterology"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-2-199507150-00009"},{"key":"e_1_2_7_22_2","first-page":"A1031","article-title":"The place for methotrexate in the treatment of refractory Crohn\u2019s disease","volume":"112","author":"Mahadevan U","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_7_23_2","first-page":"646","article-title":"Rapid closure of Crohn\u2019s disease fistulas with continuous intravenous cyclosporin A","volume":"88","author":"Hanauer SB","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta7030"},{"key":"e_1_2_7_25_2","first-page":"3","article-title":"Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn\u2019s disease: when and how were the seton drains removed?","volume":"57","author":"Tanaka S","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_7_26_2","first-page":"92","article-title":"Diagnosis and management of fistulizing Crohn\u2019s disease","volume":"6","author":"Nielsen OH","year":"2009","journal-title":"Nature"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02786.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(02)05909-9"}],"container-title":["Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1318.2012.03124.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1463-1318.2012.03124.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T20:29:03Z","timestamp":1697660943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1463-1318.2012.03124.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/j.1463-1318.2012.03124.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1318.2012.03124.x","archive":["Portico"],"relation":{},"ISSN":["1462-8910","1463-1318"],"issn-type":[{"value":"1462-8910","type":"print"},{"value":"1463-1318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,25]]},"assertion":[{"value":"2013-01-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}